top of page

Transformative Oral Medicines for Severe RNA-Mediated Diseases

Small molecules, big difference

Expansion Therapeutics has significantly expanded on scientific founder Matt Disney’s breakthrough work in addressing Small Molecules interacting with RNA (SMiRNA).

The World of SMiRNA™

Targeting RNA, Curing Disease

for Major Neurological Diseases

bottom of page